State Street Corp Charles River Laboratories International, Inc. Transaction History

State Street Corp

  • $2.21 Trillion
  • Q1 2024

A detailed history of State Street Corp transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, State Street Corp holds 2,094,112 shares of CRL stock, worth $436 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,094,112
Previous 2,059,785 1.67%
Holding current value
$436 Million
Previous $487 Million 16.53%
% of portfolio
0.03%
Previous 0.02%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$203.52 - $273.43 $6.99 Million - $9.39 Million
34,327 Added 1.67%
2,094,112 $567 Million
Q4 2023

Feb 14, 2024
BUY
$164.52 - $238.84 $5.59 Million - $8.12 Million
33,985 Added 1.68%
2,059,785 $487 Million
Q3 2023

Nov 14, 2023
SELL
$194.44 - $217.61 $12.7 Million - $14.2 Million
-65,217 Reduced 3.12%
2,025,800 $397 Million
Q2 2023

Aug 14, 2023
BUY
$183.71 - $210.25 $6.95 Million - $7.95 Million
37,816 Added 1.84%
2,091,017 $440 Million
Q1 2023

May 15, 2023
SELL
$191.89 - $259.92 $2.51 Million - $3.4 Million
-13,088 Reduced 0.63%
2,053,201 $414 Million
Q4 2022

Feb 14, 2023
BUY
$197.11 - $250.07 $6.93 Million - $8.79 Million
35,148 Added 1.73%
2,066,289 $450 Million
Q3 2022

Nov 15, 2022
BUY
$182.44 - $250.54 $3.48 Million - $4.78 Million
19,084 Added 0.95%
2,031,141 $400 Million
Q2 2022

Aug 15, 2022
SELL
$204.13 - $302.4 $2.33 Million - $3.45 Million
-11,420 Reduced 0.56%
2,012,057 $431 Million
Q1 2022

May 16, 2022
SELL
$255.51 - $362.11 $1.87 Million - $2.65 Million
-7,318 Reduced 0.36%
2,023,477 $575 Million
Q4 2021

Feb 14, 2022
BUY
$351.38 - $448.68 $25.8 Million - $32.9 Million
73,315 Added 3.75%
2,030,795 $765 Million
Q3 2021

Nov 15, 2021
BUY
$372.64 - $458.3 $21.9 Million - $26.9 Million
58,726 Added 3.09%
1,957,480 $808 Million
Q2 2021

Aug 16, 2021
BUY
$294.17 - $371.65 $220 Million - $278 Million
748,211 Added 65.03%
1,898,754 $702 Million
Q1 2021

May 17, 2021
SELL
$249.67 - $299.48 $2.29 Million - $2.75 Million
-9,170 Reduced 0.79%
1,150,543 $333 Million
Q4 2020

Feb 16, 2021
BUY
$222.0 - $252.62 $5.45 Million - $6.2 Million
24,537 Added 2.16%
1,159,713 $290 Million
Q3 2020

Nov 10, 2020
SELL
$175.56 - $226.45 $10.8 Million - $13.9 Million
-61,480 Reduced 5.14%
1,135,176 $257 Million
Q2 2020

Aug 14, 2020
BUY
$118.84 - $189.72 $5.31 Million - $8.48 Million
44,689 Added 3.88%
1,196,656 $209 Million
Q1 2020

May 11, 2020
BUY
$98.9 - $178.34 $114 Million - $205 Million
1,151,967 New
1,151,967 $145 Million

Others Institutions Holding CRL

# of Institutions
726
Shares Held
51.3M
Call Options Held
183K
Put Options Held
346K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.6B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email